I nfiltration of the islets of Langerhans by blood mononuclear cells (insulitis) is a well-recognized feature of type I (insulin-dependent) diabetes mellitus, both in human subjects (1) and in rodents with spontaneous diabetes (2,3). This insulitis lesion suggests that immune cellmediated processes are responsible for the destruction of islet p-cells. However, the precise mechanisms by which lymphocytes, macrophages/monocytes, and natural killer (NK) cells may damage islet (3-cells remain to be identified. Interleukin 1 (IL-1), a cytokine product of macrophages/ monocytes and NK cells, has been reported to produce functional and structural damage to isolated islets (4,5). In other reports, however, IL-1 was shown to inhibit insulin secretion in a reversible fashion, and the islet cells were not destroyed (6,7). Because cytokines may interact synergistically (8), we sought to determine if IL-1, tumor necrosis factor (TNF; another cytokine product of macrophage/monocyte and NK cells), or the T-lymphocyte products IL-2, lymphotoxin (LT), and (immune) interferon-7 (IFN-7) acting singly or in combination might be cytotoxic to islet cells. For this purpose, a sensitive and quantitative assay for measuring islet cell killing was developed that employed 51 Cr-labeled rat islet cells in monolayer culture.
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MATERIALS AND METHODS
Islet cell monolayer cultures. Islets were isolated from adult male and female Wistar-Furth-derived BioBreeding/Worcester (BB/W) rat sublines bred for resistance to diabetes (A. Like, University of Massachusetts Medical School, Worcester, MA) and from Wistar-Furth or Lewis rats (HarlanSprague-Dawley, Indianapolis, IN). The islets were isolated by a modification of the collagenase enzymatic digestion method (9) and dissociated into single cells by incubation at 37°C for 10 min in Ca 2+ -and Mg 2+ -free Hanks' balanced salt solution supplemented with 0.5 mg/ml trypsin and 0.2 mg/ml EDTA. Cell viability was >85%, and -8 0 % of the cells were p-cells (10) . The islet cells were suspended at 0.3 x 10 6 /ml in RPM1-1640 medium (Gibco, Grand Island, NY) containing 100 U/ml penicillin, 100 ^g/ml streptomycin, 6 mM HEPES, and 10% heat-inactivated fetal calf serum (complete medium) and further supplemented with 0.1 mM 3-isobutyl-1-methylxanthine (IBMX) to promote islet cell reaggregation and monolayer formation (11) . The cells were seeded in this medium (3 x 10 4 /well) in 96-well half-area microculture plates (Costar, Cambridge, MA) and incubated in a humidified incubator at 37°C in 95% air/5% CO 2 . After 5-7 days, the islet cells had reaggregated in small clusters of -10-100 cells attached to the bottom of the wells and spread out in monolayer. Islet cell cytotoxicity assay. Islet cell monolayer cultures were labeled by incubation at 37°C with 2 jxCi washed again 4 times. The cytokines were diluted in complete medium and added (150 |xl/well in quadruplicate) to the islet cultures, and the plates were incubated at 37°C for 4 days. An aliquot (100 jxl) of medium was collected from each well and counted in an LKB 1272 7-counter (Gaithersburg, MD). Percent specific cell lysis was calculated as 100% x (test medium cpm-spontaneous cpm)/(total cpmspontaneous cpm). Spontaneous release of 51 Cr measured in wells incubated in complete medium alone was 10-20% of total 51 Cr release, measured by dissolving the cells in 4% Triton X-100 for 6 h. The islet p-cell toxin streptozocin (STZ) was used to validate and standardize the cytotoxicity assay. STZ (Upjohn, Kalamazoo, Ml) was dissolved in citrate buffer (pH 4.6) in a stock solution of 1.67 mg/ml and diluted in complete medium immediately before use. Cytokine preparations. Recombinant (r) human IL-1p (1.3 x 10 7 U/mg) and r human IL-2 (5.8 x 10 6 U/mg) were purchased from Collaborative Research (Bedford, MA); r human TNF (TNF-7, 4 x 10 7 U/mg), r human IFN-7 (2 to 4 x 10 7 U/mg), and r mouse IFN-7 (1.3 x 10 7 U/mg) were kindly provided by B. Carswell (Sloan-Kettering, New York); r human lymphotoxin (LT or TNF-p, 1.2 x 10 8 U/mg) was provided by M. Shepard (Genentech, South San Francisco, CA); and r rat IFN-7 (4 x 10 6 U/mg) was a gift from P.H. van der Meide (Primate Center, TNO, Rijswijk, The Netherlands). Mouse IFN-a/p (2.8 x 10 5 U/mg) was the unfractionated mixture (~1:10, a:p) produced by a mouse L-cell line (Lee BioMolecular Research, San Diego, CA).
RESULTS
Rat and mouse IFN-7 were the only cytokines, tested singly, that produced significant lytic effects (>5% specific 51 Cr release) on the islet cell monolayers (Table 1) . Neither human IFN-7 nor mouse IFN-a/p was cytotoxic (1-10 4 U/ml). Also, IL-1 and IL-2 (1-100 U/ml) and TNF and LT (1-10 4 U/ml) were not cytotoxic to islet cells when added alone. When added together, the following combinations of cytokines showed cytotoxic effects: TNF (or LT) plus IL-1, rat (or mouse) IFN-7 plus IL-1, and rat (or mouse) IFN-7 plus TNF orLT.
The dose-dependent synergistic cytotoxic effects of rat IFN-7, TNF, and IL-1 on the islet cells are shown in Fig. 1 . The small dose-dependent cytotoxic effect of IFN-7 (7.6 ± 0.3% with rat IFN-7, 10 3 U/ml) was markedly potentiated by TNF (10 2 and 10 3 U/ml; 15.0 ± 2.9 and 36.8 ± 2.4%, respectively) or by IL-1 (0.1 and 5 U/ml; 17.0 ± 2.9 and 26.4 ± 4.2%, respectively), whereas neither TNF nor IL-1, acting singly, were active. A maximum effect was obtained with the triple combination of 10 3 U/ml IFN-7, 10 3 U/ml TNF, and 5 U/ml IL-1 (47.2 ± 4.7%). The synergistic cytotoxic effects of IFN-7, TNF, and IL-1 to destroy the islet cell monolayers was clearly evident by phase-contrast microscopy (Fig. 2) . Similar results were observed with monolayers prepared from islets isolated from BB/W diabetes-resistant Wistar-Furth or Lewis rats.
DISCUSSION
This study was designed to determine if any of the known polypeptide molecules (cytokines) produced by cells that infiltrate pancreatic islets in type I diabetes might be directly cytotoxic to islet cells in vitro. In preliminary studies, we failed to detect any lytic effects of cytokines on freshly isolated and dissociated rat islet cells with a conventional 6-to 12-h 51 Cr-release cytotoxicity assay (12) . Therefore, we developed an islet cell cytotoxicity assay that detects lytic effects over a longer period. A 4-day incubation was necessary to detect the full lytic effect of the p-cell toxin STZ, in agreement with the report that islet mass decreased progressively over 4 days after a single exposure to STZ in vitro (13) .
The islet cell cytotoxicity assay was sensitive, consistently detecting the small (6-10%) cytolytic effects of IFN-7, in agreement with the minimal effects seen by microscopy. The cytotoxic effect of IFN-7 was relatively species specific, being observed with rat and mouse (murine) IFN-7 but not with human IFN-7 and was subclass specific, mouse IFNa/p being inactive. These findings point to a particular sensitivity of islet cells to IFN-7, the immune interferon produced by T-lymphocytes and NK cells activated by antigenspecific and nonspecific stimuli.
With the recent availability of homogeneous recombinant cytokines (as used in this study), it has become apparent that IFN-7 has strong synergistic cytostatic or cytolytic effects with other products of cells of the immune system, including TNF and LT (14, 15) . Also, TNF and IL-1 have been reported to exert synergistic cytostatic and cytolytic effects on cloned human melanoma cells (16) . Similarly, we demonstrate a strong synergy between IFN-7, TNF (or LT), and IL-1 to kill normal rat islet cells in monolayer culture. Whereas TNF or LT (1-10 4 U/ml) and IL-1 (1-100 U/ml), acting singly, did not have any cytotoxic effects on islet cells and IFN-7 had only a small effect, combination of any two of these cytokines produced synergistic cytotoxic effects, and com- Rat islet cell monolayers were incubated for 4 days with cytokines alone or in combination with interleukin i p (IL-1 p; 10 U/ml), IL-2 (10 U/ml), IL-2 (10 U/ml), tumor necrosis factor (TNF; 100 U/ml), or lymphotoxin (LT; 100 U/ml), all recombinant human products. Interferons (IFN) of different species (as shown) were tested at 100 U/ml. Mean values ± SE for percent specific 51 Cr release above spontaneous release (14.0%) are shown for quadruplicate wells. Streptozocin (100 ng/ml) gave 75.0 ± 4.8% specific 51 Cr release in this experiment. inflammatory cells, e.g., macrophages (18) and NK cells (19) and mediators of tissue damage, e.g., free radicals (20) . Support for an important role of low-molecular-weight soluble mediators in damaging islet cells is provided by the observation that rat insulinoma cells and islet cells placed in semipermeable capsules are killed when implanted in spontaneously diabetic nonobese diabetic mice (21) .
We did not determine whether IFN-7, alone or together with TNF, induced MHC class II molecules on islet cells, as reported by others (22, 23) . However, because we have demonstrated that TNF and IL-1 can act synergistically with IFN--y to kill islet cells, it appears that these cytokines may be .directly cytotoxic to islet cells independent of inducing class II molecules to trigger immune responses against the islet cells. Evidence favors the interpretation that aberrant expression of MHC class II molecules on islet (3-cells may be a marker for IFN-7 production by activated T-lymphocytes (24) . Indeed, serum levels of IFN-7 have been reported to be increased in patients with autoimmune disease, including some children with newly diagnosed type I diabetes (25) . An obligatory role for IFN-7 in autoimmune disease has been suggested by the recent report that IFN-7 accelerated autoimmune lupuslike nephritis in F, (NZB x NZW) mice, and monoclonal antibodies to IFN-7 protected against the disease (26) .
In summary, this study reveals that the immunomodulatory polypeptide products (cytokines) of lymphocytes, macrophages/monocytes, and NK cells of the immune system (IFN-7, TNF, LT, and IL-1) can act synergistically to kill normal rat islet cells in monolayer culture. It remains to be determined whether these actions in vitro may also occur in vivo and thereby contribute to immune cell-mediated destruction of islet p-cells in type I diabetes.
